IBtk Activators
The class of IBtk Activators largely comprises compounds that modulate various kinases, especially those that intersect with Btk (Bruton's tyrosine kinase) signaling. This emphasis on kinases arises from IBtk's known interactions with Btk. Compounds such as Ibrutinib, Acalabrutinib, and Zanubrutinib specifically target Btk and by altering Btk's activity, they might indirectly shape IBtk's function within the cell.
Syk kinase also emerges as a focal point, with compounds like BAY 61-3606, R406, and Fostamatinib aiming at this kinase. The relevance of Syk arises from its positioning upstream of Btk in certain signaling cascades. By modulating Syk's activity, these compounds can influence the milieu in which IBtk operates. Additionally, the phosphatidylinositol 3-kinase (PI3K) pathway, which operates in parallel or sometimes upstream to Btk, becomes pertinent. Compounds like Duvelisib, Idelalisib, and Copanlisib, which target this pathway, can indirectly determine IBtk's activity by shaping the overall signaling landscape of the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Known to inhibit Btk, it may indirectly alter IBtk's interactions and downstream pathways. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Targets ABL kinase which has overlapping pathways with Btk, potentially affecting IBtk indirectly. | ||||||
Syk Inhibitor IV, BAY 61-3606 HCl | 732983-37-8 | sc-202351 | 2 mg | $327.00 | 25 | |
Inhibits Syk kinase, a signaling molecule upstream of Btk, and can influence IBtk's functional context. | ||||||
R406 | 841290-81-1 | sc-364595 sc-364595A | 2 mg 10 mg | $163.00 $377.00 | 16 | |
Inhibits Syk kinase, affecting signaling pathways related to Btk, potentially influencing IBtk. | ||||||
R788 | 901119-35-5 | sc-364597 sc-364597A | 2 mg 50 mg | $405.00 $4000.00 | 2 | |
Targets Syk kinase and might influence Btk related signaling, thus affecting IBtk indirectly. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | $255.00 | ||
Another inhibitor of Btk, it may modulate IBtk's interactions and downstream effects. | ||||||
BAY 80-6946 | 1032568-63-0 | sc-503264 | 5 mg | $562.00 | ||
PI3K inhibitor which can influence pathways upstream or parallel to Btk, potentially affecting IBtk. | ||||||